• Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town
Afrigen, a biotechnology company based in Cape Town, South Africa, is developing Africa’s first proprietary COVID-19 vaccine. Kristin Palitza/picture alliance via Getty Images

How trying to copy a COVID vaccine changes the outlook for African countries

With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.

Contact Kelly for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision
  • Location: Cape Town, South Africa
  • Article Feed
  • Joined